CRNX
Congressional ActivityCrinetics Pharmaceuticals, Inc. -
Common Stock (CRNX) [ST]
ARIA INTELLIGENCE BRIEF
Disclosure records show two members of Congress — Gil Cisneros and Josh Gottheimer — have reported a combined four trades in this Health Care sector security since September 2024, with all four transactions recorded as purchases and none as sales. The most recent disclosed trade is dated March 3, 2026, indicating activity has continued into the near term. No bipartisan co-trading clusters are recorded for this ticker, and the two members represent the entirety of congressional disclosure interest in the name. Separately, one executive-branch official has disclosed one transaction in the same security, with the closest congressional and executive purchases falling 63 days apart in the independent public filing record.
Signal Congress surfaces public disclosure data. This is not investment advice and does not imply wrongdoing.
TOTAL TRADES
4
BUYS
4
SELLS
0
MEMBERS
2
unique traders
BIPARTISAN CLUSTERS
0
AVG ALPHA 60D
-4.16%
vs SPY benchmark
CRNX timeline5 trades · Congress + cabinet · convergence
Positioned by disclosure date. Click any marker for its source filing.
CongressCabinetContract cut8-K13D▲ buy ▼ sell ◆ n/a ■ event
EXECUTIVE HOLDINGS
Primary-source OGE 278-T disclosures
| OFFICIAL | AGENCY | DATE | TYPE | AMOUNT |
|---|---|---|---|---|
Feinberg, Stacey | Dec 30, 25 | BUY | $1K–$15K |
4 trades
Congressional trading data from STOCK Act filings. Not investment advice.